Velda J Gonzalez1, Susan McMillan2, Elsa Pedro3, Maribel Tirado-Gomez4, Leorey N Saligan5. 1. Postdoctoral Fellow, College of Nursing, University of South Florida, Tampa, FL. 2. Distinguished Professor and Thompson Professor of Oncology Nursing and Quality of Life at the University of South Florida College of Nursing, FL. 3. Assistant Professor, School of Pharmacy, University of Puerto Rico Medical Science Campus, San Juan, PR. 4. Assistant Professor, Department of Hematology Oncology, University of Puerto Rico Medical Science Campus, San Juan, PR. 5. Tenure-Track Investigator, Chief, Symptoms Biology Unit, NINR/NIH.
Abstract
OBJECTIVE: To examine the health related quality of life (HRQOL) experienced by 79 Puerto Rican adults during cancer treatments. METHODS: This study used a descriptive, cross-sectional design. Participants completed a demographics form and the Functional Assessment of Cancer Therapy-General QOL questionnaire (FACT-G). Descriptive statistics were generated. RESULTS: Participants were ages 28-78; most of the participants had breast (38.0%), prostate (14.0%) and cervical and ovarian cancers (10.1%) treated with chemotherapy (45.6%). The participants had a mean total score on the FACT-G of 75.2 (SD = 18.9). As a group, the functional well-being was the most affected (mean 17.2, SD 6.8), and the Social/Familial was the least affected (mean 20.7, SD 6.0). CONCLUSION: Cancer is the leading cause of death in the island of Puerto Rico. Female Puerto Rican cancer patients in this study sample had increased risk for experiencing worse: overall HRQOL, physical well-being and emotional well-being compared to males. Given that the Hispanic oncology population does not always report symptoms, risking under-assessment and under management, this suggests there may be a greater need for HRQOL surveillance for this population.
OBJECTIVE: To examine the health related quality of life (HRQOL) experienced by 79 Puerto Rican adults during cancer treatments. METHODS: This study used a descriptive, cross-sectional design. Participants completed a demographics form and the Functional Assessment of Cancer Therapy-General QOL questionnaire (FACT-G). Descriptive statistics were generated. RESULTS:Participants were ages 28-78; most of the participants had breast (38.0%), prostate (14.0%) and cervical and ovarian cancers (10.1%) treated with chemotherapy (45.6%). The participants had a mean total score on the FACT-G of 75.2 (SD = 18.9). As a group, the functional well-being was the most affected (mean 17.2, SD 6.8), and the Social/Familial was the least affected (mean 20.7, SD 6.0). CONCLUSION:Cancer is the leading cause of death in the island of Puerto Rico. Female Puerto Rican cancerpatients in this study sample had increased risk for experiencing worse: overall HRQOL, physical well-being and emotional well-being compared to males. Given that the Hispanic oncology population does not always report symptoms, risking under-assessment and under management, this suggests there may be a greater need for HRQOL surveillance for this population.
Entities:
Keywords:
Cancer Treatments; Health Related Quality of Life; Puerto Ricans
Authors: Winnie K W So; Doris Y P Leung; Simone S M Ho; Eve T L Lai; Janet W H Sit; Carmen W H Chan Journal: Eur J Oncol Nurs Date: 2012-12-10 Impact factor: 2.398
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Cleo A Samuel; Laura C Pinheiro; Katherine E Reeder-Hayes; Jennifer S Walker; Giselle Corbie-Smith; Shekinah A Fashaw; Cheryl Woods-Giscombe; Stephanie B Wheeler Journal: Breast Cancer Res Treat Date: 2016-09-06 Impact factor: 4.872
Authors: Velda J Gonzalez; Jason Beckstead; Maureen Groer; Susan McMillan; Desiree Ortiz; Sara Marrero; Leorey N Saligan Journal: P R Health Sci J Date: 2019-06 Impact factor: 0.705
Authors: Velda J Gonzalez-Mercado; Sara Marrero; Josué Pérez-Santiago; Maribel Tirado-Gómez; Miguel A Marrero-Falcón; Elsa Pedro; Leorey N Saligan Journal: P R Health Sci J Date: 2021-03 Impact factor: 0.600